THYROID EYE DISEASE (TED)

Clinical trials for THYROID EYE DISEASE (TED) explained in plain language.

Never miss a new study

Get alerted when new THYROID EYE DISEASE (TED) trials appear

Sign up with your email to follow new studies for THYROID EYE DISEASE (TED), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 5 Not yet finished but already full! 1 Completed 2

New injection treatment tested for bulging eyes condition

Disease control Ongoing

This study is testing whether VRDN-003 injections are safe and tolerable for people with Thyroid Eye Disease (TED), which causes eye bulging and discomfort. The trial involves 321 participants who receive injections every 4 or 8 weeks for 24 weeks. Researchers are measuring side …

Matched conditions: THYROID EYE DISEASE (TED)

Phase: PHASE3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control

Last updated Mar 11, 2026 14:54 UTC

THYROID EYE DISEASE (TED)

Get alerted when new THYROID EYE DISEASE (TED) trials appear

New injection treatment tested for bulging eyes condition